Huayan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Huayan Zhang has a total of 274 co-authors. Here are the top co-authors by number of shared publications:
- Ge Yang
Division of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong, China
4 shared publications Haresh Kirpalani
The Children's Hospital of Philadelphia Division of Neonatology
4 shared publicationsKathleen Nilan
The Children's Hospital of Philadelphia Division of Neonatology
4 shared publicationsYuan Yuan
Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
4 shared publicationsChunxiao Fang
Department of Pediatric, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
3 shared publicationsFan Li
Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
3 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Integrative transcriptomic and functional profiling reveals neutrophil-associated immune dysregulation in bronchopulmonary dysplasia
- 5 August 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Open AccessIntegrative transcriptomic and functional profiling reveals neutrophil-associated immune dysregulation in bronchopulmonary dysplasia
- Open Access
- 16 June 2026
- Published by Springer Nature in Molecular Medicine
- Vol. 32 (1)
Gut dysbiosis modulates hyperoxia-induced bronchopulmonary dysplasia by promoting EMT through activating TLR4/NF-κB pathway
Background: Bronchopulmonary dysplasia (BPD) is a major cause of morbidity and mortality in premature infants. Although gut microbial dysbiosis is implicated in BPD pathogenesis, the underlying mechanisms are poorly defined. This study aims to elucidate the specific pathway through which gut dysbiosis drives BPD pathology and to identify potential therapeutic targets. Methods: The experimental BPD model was established by hyperoxia (FiO 2 85%) in neonatal mice from postnatal days 1 to 14. Pulmonary alveolarization and inflammation were analyzed at postnatal day 15. The modulatory role of gut microbiota was assessed using antibiotic-induced dysbiosis and fecal microbiota transplantation (FMT) from normoxic mice. Gut microbiome analysis was performed using 16S rRNA gene sequencing. The specific signaling pathway was investigated using a pharmacological inhibitor of TLR4. Furthermore, the molecular mechanisms were investigated through western blotting, real-time quantitative PCR, ELISA, and immunofluorescence. Results: Hyperoxia exposure induced impaired alveolarization, disrupted gut barrier integrity, and gut dysbiosis. These pathological changes were accompanied by elevated pulmonary inflammation, potent activation of the TLR4/NF-κB pathway, and upregulation of epithelial-mesenchymal transition (EMT) associated markers. These changes were exacerbated by early postnatal antibiotic administration, whereas FMT from normoxic mice rescued these phenotypes, restored gut barrier function, suppressed TLR4/NF-κB signaling, and reversed EMT progression. Notably, pharmacological inhibition of TLR4 mirrored the protective effects of FMT, effectively attenuating hyperoxia-induced lung injury and EMT. Conclusions: Our findings establish a mechanistic link for the gut-lung axis in BPD, demonstrating that gut dysbiosis is a critical modulator of lung development impairment and pathological EMT via activation of the TLR4/NF-κB pathway.
- 16 June 2026
- Published by Springer Nature in Molecular Medicine
- Vol. 32 (1)
Open AccessGut dysbiosis modulates hyperoxia-induced bronchopulmonary dysplasia by promoting EMT through activating TLR4/NF-κB pathway
Background: Bronchopulmonary dysplasia (BPD) is a major cause of morbidity and mortality in premature infants. Although gut microbial dysbiosis is implicated in BPD pathogenesis, the underlying mechanisms are poorly defined. This study aims to elucidate the specific pathway through which gut dysbiosis drives BPD pathology and to identify potential therapeutic targets. Methods: The experimental BPD model was established by hyperoxia (FiO 2 85%) in neonatal mice from postnatal days 1 to 14. Pulmonary alveolarization and inflammation were analyzed at postnatal day 15. The modulatory role of gut microbiota was assessed using antibiotic-induced dysbiosis and fecal microbiota transplantation (FMT) from normoxic mice. Gut microbiome analysis was performed using 16S rRNA gene sequencing. The specific signaling pathway was investigated using a pharmacological inhibitor of TLR4. Furthermore, the molecular mechanisms were investigated through western blotting, real-time quantitative PCR, ELISA, and immunofluorescence. Results: Hyperoxia exposure induced impaired alveolarization, disrupted gut barrier integrity, and gut dysbiosis. These pathological changes were accompanied by elevated pulmonary inflammation, potent activation of the TLR4/NF-κB pathway, and upregulation of epithelial-mesenchymal transition (EMT) associated markers. These changes were exacerbated by early postnatal antibiotic administration, whereas FMT from normoxic mice rescued these phenotypes, restored gut barrier function, suppressed TLR4/NF-κB signaling, and reversed EMT progression. Notably, pharmacological inhibition of TLR4 mirrored the protective effects of FMT, effectively attenuating hyperoxia-induced lung injury and EMT. Conclusions: Our findings establish a mechanistic link for the gut-lung axis in BPD, demonstrating that gut dysbiosis is a critical modulator of lung development impairment and pathological EMT via activation of the TLR4/NF-κB pathway.
- Open Access
- 19 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
CQMUH-011 mitigated LPS-induced acute lung injury in neonatal rabbits
The online version contains supplementary material available at 10.1038/s41598-026-49167-x.
- 19 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessCQMUH-011 mitigated LPS-induced acute lung injury in neonatal rabbits
The online version contains supplementary material available at 10.1038/s41598-026-49167-x.
- Open Access
Variations in bronchopulmonary dysplasia prevalence and outcomes by definition: a multicentre cohort study from the Chinese Neonatal Network
Objectives: To examine bronchopulmonary dysplasia (BPD) epidemiological data in Chinese very preterm infants and compare agreement between four diagnostic definitions and their predictive accuracy for discharge outcomes. Design: Observational epidemiologic study of a multicentre cohort of the Chinese Neonatal Network (CHNN). Setting: Tertiary neonatal intensive care units participating in the CHNN. Participants: 42 664 preterm infants born at <32 weeks’ gestational age from 2019 to 2023. Measures: BPD was diagnosed using four definitions: Shennan 1988, the National Institute of Child Health and Human Development (NICHD) 2001 and 2018, and the Neonatal Research Network (NRN) 2019 definitions. BPD prevalence and severity were examined. Agreement was assessed using kappa statistics. Predictive accuracy for discharge outcomes was evaluated using c-statistics from multivariable generalised estimating equation models. Results: Among 42 664 infants (mean gestational age, 29.0 weeks; 43.1% females), BPD prevalence varied significantly: Shennan 1988: 37.0%, NICHD 2001: 51.1%, NICHD 2018: 37.0%, NRN 2019: 37.0%. NICHD 2001 and 2018 definitions classified more infants as severe BPD (16.4% and 10.1%, respectively), while NRN 2019 classified more as grade 2 (moderate; 15.0%). Shennan 1988 showed good agreement with NICHD 2018 (κ=1.0) and Jensen 2019 (κ=1.0). Shennan 1988 (c-statistic range: 0.921–0.974), NICHD 2018 (0.948-0.978) and NRN 2019 (0.949-0.982) demonstrated higher discriminative accuracy for discharge outcomes than NICHD 2001 (0.854–0.925). Conclusions: This study found a high prevalence of BPD among very preterm infants in China, varying by definitions. The Shennan 1988, NICHD 2018 and NRN 2019 definitions showed good agreement and better predictive accuracy for outcomes at discharge compared with NICHD 2001. These definitions could be prioritised for clinical use in our population.
Open AccessVariations in bronchopulmonary dysplasia prevalence and outcomes by definition: a multicentre cohort study from the Chinese Neonatal Network
Objectives: To examine bronchopulmonary dysplasia (BPD) epidemiological data in Chinese very preterm infants and compare agreement between four diagnostic definitions and their predictive accuracy for discharge outcomes. Design: Observational epidemiologic study of a multicentre cohort of the Chinese Neonatal Network (CHNN). Setting: Tertiary neonatal intensive care units participating in the CHNN. Participants: 42 664 preterm infants born at <32 weeks’ gestational age from 2019 to 2023. Measures: BPD was diagnosed using four definitions: Shennan 1988, the National Institute of Child Health and Human Development (NICHD) 2001 and 2018, and the Neonatal Research Network (NRN) 2019 definitions. BPD prevalence and severity were examined. Agreement was assessed using kappa statistics. Predictive accuracy for discharge outcomes was evaluated using c-statistics from multivariable generalised estimating equation models. Results: Among 42 664 infants (mean gestational age, 29.0 weeks; 43.1% females), BPD prevalence varied significantly: Shennan 1988: 37.0%, NICHD 2001: 51.1%, NICHD 2018: 37.0%, NRN 2019: 37.0%. NICHD 2001 and 2018 definitions classified more infants as severe BPD (16.4% and 10.1%, respectively), while NRN 2019 classified more as grade 2 (moderate; 15.0%). Shennan 1988 showed good agreement with NICHD 2018 (κ=1.0) and Jensen 2019 (κ=1.0). Shennan 1988 (c-statistic range: 0.921–0.974), NICHD 2018 (0.948-0.978) and NRN 2019 (0.949-0.982) demonstrated higher discriminative accuracy for discharge outcomes than NICHD 2001 (0.854–0.925). Conclusions: This study found a high prevalence of BPD among very preterm infants in China, varying by definitions. The Shennan 1988, NICHD 2018 and NRN 2019 definitions showed good agreement and better predictive accuracy for outcomes at discharge compared with NICHD 2001. These definitions could be prioritised for clinical use in our population.
- Open Access
- 27 November 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 966
The prediction of phototherapy by early postnatal ETCOc in Chinese newborns
The clinical significance of early postnatal ETCOc in the prediction of phototherapy (PT) for neonatal hyperbilirubinemia has not been fully characterized.
- 27 November 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 966
Open AccessThe prediction of phototherapy by early postnatal ETCOc in Chinese newborns
The clinical significance of early postnatal ETCOc in the prediction of phototherapy (PT) for neonatal hyperbilirubinemia has not been fully characterized.
- Open Access
- 29 October 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (12) , 4310
Author Correction: Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
- 29 October 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (12) , 4310
Open AccessAuthor Correction: Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
- Open Access
- 2 October 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-7
Neonatal early-onset sepsis caused by Streptococcus Gallolyticus subsp. Pasteurianus with severe pulmonary hypertension and leukemoid reaction: a case report
Streptococcus gallolyticus subsp. pasteurianus (SGSP) is an uncommon cause of neonatal early-onset sepsis (EOS). We present a case of neonatal EOS attributed to SGSP in an infant complicated by meconium aspiration syndrome (MAS) and congenital pneumonia. The infant developed severe pulmonary hypertension and exhibited a leukemoid reaction during recovery. The clinical features of this case are rare, and a comprehensive review of her peripartum and follow-up data could enhance our understanding of this organism. This is a full-term female neonate born to a healthy mother via cesarean section due to suspected fetal distress with meconium-stained amniotic fluid. She required resuscitation in the delivery room and was subsequently admitted to the neonatal intensive care unit for respiratory distress. Both the mother and the baby exhibited fever after delivery, and cultures from the baby’s blood and amniotic fluid revealed the same strain of SGSP. The baby had MAS and developed severe pulmonary hypertension, which was successfully treated with a comprehensive approach that included ampicillin, high-frequency oscillatory ventilation, inhaled nitric oxide, fluid resuscitation, and vasopressors. A significant increase in the white blood cell count was noted during her clinical improvement, followed by a spontaneous decline. The baby completed a 12-day course of ampicillin and was followed up to 1 year of age, during which she thrived. A systematic literature review on early-onset SGSP sepsis was also conducted. SGSP infection can be associated with life-threatening complications. This case underscores the importance of considering SGSP as a potential etiology in neonatal EOS.
- 2 October 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-7
Open AccessNeonatal early-onset sepsis caused by Streptococcus Gallolyticus subsp. Pasteurianus with severe pulmonary hypertension and leukemoid reaction: a case report
Streptococcus gallolyticus subsp. pasteurianus (SGSP) is an uncommon cause of neonatal early-onset sepsis (EOS). We present a case of neonatal EOS attributed to SGSP in an infant complicated by meconium aspiration syndrome (MAS) and congenital pneumonia. The infant developed severe pulmonary hypertension and exhibited a leukemoid reaction during recovery. The clinical features of this case are rare, and a comprehensive review of her peripartum and follow-up data could enhance our understanding of this organism. This is a full-term female neonate born to a healthy mother via cesarean section due to suspected fetal distress with meconium-stained amniotic fluid. She required resuscitation in the delivery room and was subsequently admitted to the neonatal intensive care unit for respiratory distress. Both the mother and the baby exhibited fever after delivery, and cultures from the baby’s blood and amniotic fluid revealed the same strain of SGSP. The baby had MAS and developed severe pulmonary hypertension, which was successfully treated with a comprehensive approach that included ampicillin, high-frequency oscillatory ventilation, inhaled nitric oxide, fluid resuscitation, and vasopressors. A significant increase in the white blood cell count was noted during her clinical improvement, followed by a spontaneous decline. The baby completed a 12-day course of ampicillin and was followed up to 1 year of age, during which she thrived. A systematic literature review on early-onset SGSP sepsis was also conducted. SGSP infection can be associated with life-threatening complications. This case underscores the importance of considering SGSP as a potential etiology in neonatal EOS.
- Open Access
- 4 August 2025
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 21 (8) , 792-799
End-tidal CO corrected for ambient CO risk adjusted phototherapy threshold for the management of neonatal hyperbilirubinemia: a randomized clinical trial
Background: Neonatal hyperbilirubinemia risk factors determination is challenging due to the lack of quantifiable indicators for bilirubin production, resulting in phototherapy decisions made without real-time information. End-tidal carbon monoxide (CO) corrected for ambient CO (ETCOc) may be helpful for identifying hemolysis, but evidence on the application of ETCOc as a risk factor for the development of neonatal hyperbilirubinemia is scarce. This study aimed to evaluate whether the use of ETCOc to adjust neonatal hyperbilirubinemia risk categories and thus phototherapy thresholds can reduce the rate of phototherapy within the first seven days of life. Methods: This is a randomized clinical trial including near-term and term infants with a transcutaneous bilirubin $$>$$ 40th percentile within 72 hours after birth in a single center in Guangdong, China. Newborns were randomized to receive ETCOc-adjusted risk assessment or empirical assessment per local practice to establish phototherapy thresholds. The primary outcome was the rate of phototherapy within seven days of life. Secondary outcomes were postnatal hours at phototherapy, total serum bilirubin and ETCOc before phototherapy, severe hyperbilirubinemia and phototherapy duration. Results: A total of 2500 infants were enrolled and randomized. Phototherapy within seven days of life occurred in 237 infants (18.9%) in the intervention group and 281 infants (22.5%) in the control group [adjusted relative risk: 0.85; 95% confidence interval (CI): 0.73, 0.98]. The ETCOc before phototherapy was 0.28 parts per million higher (95% CI: 0.10, 0.46) in the intervention group. The rate of subsequent severe hyperbilirubinemia was not significantly different, and other secondary outcomes were comparable between the two groups. Conclusions: For near-term and term infants at risk of neonatal hyperbilirubinemia, the use of ETCOc to adjust neonatal hyperbilirubinemia risk categories can decrease the rate of phototherapy at seven days of life. Integrating the ETCOc to adjust the phototherapy threshold is helpful in the management of severe hyperbilirubinemia. Graphical- 4 August 2025
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 21 (8) , 792-799
Open AccessEnd-tidal CO corrected for ambient CO risk adjusted phototherapy threshold for the management of neonatal hyperbilirubinemia: a randomized clinical trial
Background: Neonatal hyperbilirubinemia risk factors determination is challenging due to the lack of quantifiable indicators for bilirubin production, resulting in phototherapy decisions made without real-time information. End-tidal carbon monoxide (CO) corrected for ambient CO (ETCOc) may be helpful for identifying hemolysis, but evidence on the application of ETCOc as a risk factor for the development of neonatal hyperbilirubinemia is scarce. This study aimed to evaluate whether the use of ETCOc to adjust neonatal hyperbilirubinemia risk categories and thus phototherapy thresholds can reduce the rate of phototherapy within the first seven days of life. Methods: This is a randomized clinical trial including near-term and term infants with a transcutaneous bilirubin $$>$$ 40th percentile within 72 hours after birth in a single center in Guangdong, China. Newborns were randomized to receive ETCOc-adjusted risk assessment or empirical assessment per local practice to establish phototherapy thresholds. The primary outcome was the rate of phototherapy within seven days of life. Secondary outcomes were postnatal hours at phototherapy, total serum bilirubin and ETCOc before phototherapy, severe hyperbilirubinemia and phototherapy duration. Results: A total of 2500 infants were enrolled and randomized. Phototherapy within seven days of life occurred in 237 infants (18.9%) in the intervention group and 281 infants (22.5%) in the control group [adjusted relative risk: 0.85; 95% confidence interval (CI): 0.73, 0.98]. The ETCOc before phototherapy was 0.28 parts per million higher (95% CI: 0.10, 0.46) in the intervention group. The rate of subsequent severe hyperbilirubinemia was not significantly different, and other secondary outcomes were comparable between the two groups. Conclusions: For near-term and term infants at risk of neonatal hyperbilirubinemia, the use of ETCOc to adjust neonatal hyperbilirubinemia risk categories can decrease the rate of phototherapy at seven days of life. Integrating the ETCOc to adjust the phototherapy threshold is helpful in the management of severe hyperbilirubinemia. Graphical - 16 May 2025
- Published by Elsevier in Clinica Chimica Acta
- Vol. 575, 120368
End-tidal carbon monoxide levels as a point-of-care biomarker for the early detection of hemolytic disease in Chinese neonates
- 16 May 2025
- Published by Elsevier in Clinica Chimica Acta
- Vol. 575, 120368
End-tidal carbon monoxide levels as a point-of-care biomarker for the early detection of hemolytic disease in Chinese neonates
- Open Access
- 9 December 2024
- Published by Qeios Ltd
Review of: "Annealed Stein Variational Gradient Descent for Improved Uncertainty Estimation in Full-Waveform Inversion"
A new improvement of the Stein Variational Gradient Descent is proposed in the paper. The experimental results are sufficient and persuasive. The authors use Principal Component Analysis and clustering techniques to evaluate the performance of the op...
- 9 December 2024
- Published by Qeios Ltd
Open AccessReview of: "Annealed Stein Variational Gradient Descent for Improved Uncertainty Estimation in Full-Waveform Inversion"
A new improvement of the Stein Variational Gradient Descent is proposed in the paper. The experimental results are sufficient and persuasive. The authors use Principal Component Analysis and clustering techniques to evaluate the performance of the op...